Best Practice & Research Clinical Gastroenterology
Volume 24, Issue 1 , Pages 71-77 , February 2010

Long-term follow-up of gastric lymphoma after stomach conserving treatment

  • W. Fischbach (Prof.)

      Affiliations

    • Corresponding Author InformationTel.: +49 6021 323010; fax: +49 6021 323031.

References 

  1. Fischbach W, Kolve-Goebeler M, Dragosics B, et al. Long-term results of the German–Austrian prospective multicenter study in patients with localized primary gastric B-cell lymphoma. Gastroenterology. 2001;120(Suppl. 1):A612
  2. Fischbach W, Dragosics B, Koelve-Goebeler ME, et al. Primary gastric B-cell Lymphoma: results of a prospective multicenter study. Gastroenterology. 2000;119:1191–1202
  3. Gobbi PG, Dionigi P, Barbieri F, et al. The role of surgery in the multimodal treatment of primary gastric non-Hodgkin's lymphomas. A report of 76 cases and review of the literature. Cancer. 1990;65:2528–2536
  4. Maor MH, Velasquez WS, Fuller LM, et al. Stomach conservation in stages IE and IIE gastric non-Hodgkin's lymphoma. J Clin Oncol. 1990;8:266–271
  5. Koch P, del Valle F, Berdel WE, et al. Primary gastrointestinal non-Hodgkin's lymphoma: II. Combined surgical and conservative or conservative management only in localized gastric lymphoma – results of the prospective German multicenter study GIT NHL 01/92. J Clin Oncol. 2001;19:3874–3883
  6. Koch P, Probst A, Berdel WE, et al. Treatment results in localized primary gastric lymphoma: data of patients registered within the German multicenter study (GIT NHL 02/96). J Clin Oncol. 2005;23:7050–7059
  7. Aviles A, Nambo MJ, Neri N, et al. The role of surgery in primary gastric lymphoma: results of a controlled clinical trial. Ann Surg. 2004;240:44–50
  8. Aviles A, Nambo MJ, Neri N, et al. Mucosa-associated lymphoid tissue (MALT) lymphoma of the stomach: results of a controlled clinical trial. Med Oncol. 2005;22:57–62
  9. Fischbach W, Goebeler M, Schramm St. Outcome and quality of life favor a conservative treatment of patients with primary gastric Nhl's. Results of a prospective randomized study. Gastroenterology. 2008;143(Suppl. 1):A-296
  10. Fischbach W, Malfertheiner P, Hoffmann JC, et al. S3-Leitlinie “Helicobacter pylori und gastroduodenale Ulkuskrankheit” der Deutschen Gesellschaft für Verdauungs- und Stoffwechsel-krankheiten (DGVS) in Zusammenarbeit mit der Deutschen Gesellschaft für Hygiene und Mikrobiologie, Gesellschaft für Pädiatrische Gastroenterologie und Ernährung e.V. und der Deutschen Gesellschaft für Rheumatologie – AWMF-Register-Nr. 021/001. Z Gastroenterol. 2009;47:68–102
  11. Wotherspoon AC, Doglioni C, Diss TC, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue. Lancet. 1993;342:575–577
  12. Fischbach W, Goebeler-Kolve ME, Dragosics B, et al. Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication: experience from a large prospective series. Gut. 2004;53:34–37
  13. Wündisch T, Thiede C, Morgner A, et al. Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication. J Clin Oncol. 2005;23(31):1–7
  14. Wündisch T, Dieckhoff P, Gunther A, et al. 10-Year follow-up of 120 patients with gastric MALT lymphoma after Helicobacter pylori eradication – histological residual disease and second cancers. ASCO 2008 (8536)
  15. Lee SK, Lee YC, Chung JB, et al. Low grade gastric mucosa associated lymphoid tissue lymphoma: treatment strategies based on 10 year follow-up. World J Gastroenterol. 2004;10:223–226
  16. Nakamura S, Matsumoto T, Suekane H, et al. Long-term clinical outcome of Helicobacter pylori eradication for gastric mucosa-associated lymphoid tissue lymphoma with a reference to second-line treatment. Cancer. 2005;104:532–540
  17. Wündisch T, Mösch C, Neubauer A, et al. Helicobacter pylori eradication in gastric mucosa-associated lymphoid tissue lymphoma: results of a 196-patient series. Leuk Lymphoma. 2006;47:2110–2114
  18. Liu H, Ruskone-Fourmestraux A, Lavergne-Scove A, et al. Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy. Lancet. 2001;357:39–40
  19. Liu H, Ye H, Ruskone-Fourmestraux A, et al. T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology. 2002;122:1286–1294
  20. Levy M, Copie-Bergman C, Cameiro C, et al. Prognostic value of translocation t(11;18) in tumoral response of low-grade gastric lymphoma of mucosa-associated lymphoid tissue type to oral chemotherapy. J Clin Oncol. 2005;23:5061–5066
  21. Morgner A, Miehlke S, Fischbach W, et al. Complete remission of primary high-grade B-cell gastric lymphoma after cure of Helicobacter pylori infection. J Clin Oncol. 2001;19:2041–2048
  22. Chen LT, Lin JT, Tal JJ. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma. J Natl Cancer Inst. 2005;97:1345–1353
  23. Raderer M, Streubel B, Wöhrer S, et al. Successful antibiotic treatment of Helicobacter pylori negative gastric mucosa associated lymphoid tissue lymphomas. Gut. 2006;55:616–618
  24. Okada T, Hori K, Nakajima K, et al. Cases of gastric MALT lymphoma and diffuse large B-cell lymphoma associated with Okadaella gastrococcus-like organism. Gastroenterology. 2007;132(Suppl. 2):S2075
  25. Okada T, Hori K, Adkins G, et al. Okadaella gastrococcus-like immunoreactivity in the pre-neoplastic gastric mucosa. Gastroenterology. 2008;134(Suppl. 1):A-295
  26. Hancock BW, Qian W, Linch D, et al. Chlorambucil versus observation after anti-Helicobacter therapy in gastric MALT lymphomas: results of the international randomized LY03 trial. Br J Haematol. 2008;144:367–375
  27. Bonnet C, Fillet G, Mounier N, et al. CHOP alone compared with CHOP plus radiotherapy for localized aggressive lymphoma in elderly patients: a study by the group d'Ètude des Lymphomes de l'Àdulte. J Clin Oncol. 2007;25:787–792
  28. Fischbach W, Keller R, Englert D. Unusual treatment of a gastric marginal zone B-cell lymphoma of MALT type. Z Gastroenterol. 2007;45:383–386
  29. Youn JC, Lee YC, Youn YH, et al. Two cases of low grade gastric-mucosa-associated lymphoid tissue lymphoma treated by EMR. Gastrointest Endosc. 2006;64:456–460
  30. Fischbach W, Goebeler-Kolve M, Starostik P, et al. Minimal residual low-grade gastric MALT-type lymphoma after eradication of Helicobacter pylori. Lancet. 2002;360:547–548
  31. Fischbach W, Goebeler ME, Ruskone-Fourmestraux A, et al. Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch-and-wait strategy: experience from a large international series. Gut. 2007;56:1685–1687
  32. Capelle LG, de Vries AC, Looman CWN, et al. Gastric MALT lymphoma: epidemiology and high adenocarcinoma risk in a nation-wide study. Eur J Cancer. 2008;44(16):2470–2476

PII: S1521-6918(09)00163-2

doi: 10.1016/j.bpg.2009.12.005

Best Practice & Research Clinical Gastroenterology
Volume 24, Issue 1 , Pages 71-77 , February 2010

Article Tools

* Image Usage & Resolution